Mycoplasma genitalium Antimicrobial Resistance in Community and Sexual Health Clinic Patients, Auckland, New Zealand

Emerg Infect Dis. 2020 Feb;26(2):332-335. doi: 10.3201/eid2602.190533.

Abstract

Our retrospective study compared genotypic antimicrobial resistance in Mycoplasma genitalium-positive specimens collected from 48 community and 33 sexual health clinic (SHC) patients. Macrolide resistance was similar in community (75%) and SHC (76%) patients. We observed no significant difference in fluoroquinolone resistance between community (19%) and SHC (27%) patients (p = 0.66).

Keywords: Mycoplasma genitalium; New Zealand; antimicrobial resistance; bacteria; bacterial infections; genotypic antimicrobial resistance; quinolone resistance–determining region; sexually transmitted infections.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Drug Resistance, Bacterial
  • Female
  • Fluoroquinolones / pharmacology
  • Fluoroquinolones / therapeutic use
  • Humans
  • Male
  • Mycoplasma Infections / drug therapy
  • Mycoplasma Infections / epidemiology*
  • Mycoplasma genitalium / drug effects
  • Mycoplasma genitalium / isolation & purification*
  • New Zealand / epidemiology
  • Residence Characteristics
  • Retrospective Studies
  • Sexual Health
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Fluoroquinolones